Ramat Gan, Israel

Nir Agiv

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Nir Agiv: Pioneering Security Solutions

Introduction

Nir Agiv is a notable inventor based in Ramat Gan, Israel. He has made significant contributions to the field of cybersecurity through his innovative patent. His work focuses on enhancing the validation and prioritization of indicators of compromise, which is crucial in protecting systems from potential threats.

Latest Patents

Nir Agiv holds a patent titled "Automatic validations and prioritizations of indicators of compromise." This patent outlines a method that includes receiving indicator of compromise (IOC) intelligence, validating the IOC, and determining which security systems should incorporate the IOC based on various risk indicators. The validation process may utilize machine learning techniques to assess the likelihood of a threat, thereby improving the overall security posture of organizations.

Career Highlights

Nir Agiv is currently employed at The Toronto-Dominion Bank, where he applies his expertise in cybersecurity. His role involves developing and implementing advanced security measures to protect sensitive information and systems from cyber threats. His innovative approach has positioned him as a valuable asset in the field.

Collaborations

Nir has collaborated with talented professionals such as Moshe Karl and Allie David Shay. These collaborations have fostered a creative environment that encourages the development of cutting-edge security solutions.

Conclusion

Nir Agiv's contributions to cybersecurity through his patent and work at The Toronto-Dominion Bank highlight his commitment to innovation in protecting digital assets. His efforts in validating and prioritizing indicators of compromise are essential in the ongoing battle against cyber threats.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…